MB Rahastot invests in Spider Med Oy, a rapidly growing Finnish oral health care company, to support its expansion and innovative service delivery models.

Information on the Target

Spider Med Oy, founded in 2020, is a prominent Finnish company specializing in oral health care. It has rapidly established itself as a key partner for both public and private sector stakeholders in the industry. Utilizing innovative and effective operational models, Spider Med delivers its services on a national scale and currently employs over 450 dental professionals.

The founders, Joona Iso-Lotila, Arttu Rissanen, and Pinja Pesonen, remain integral to the company, overseeing its development as significant stakeholders. They are committed to enhancing Spider Med's brand and expanding its offerings to oral health professionals, underlining their dedication to quality and impactful dental care.

Industry Overview in Finland

Finland's oral health care industry has seen substantial growth, driven by an increasing demand for dental services from both private individuals and public healt

View Source

Similar Deals

Verso Capital and Armada Credit Partners Suomen Avustajapalvelut

2025

Growth Equity & Expansion Capital Home Healthcare Services Finland
Voima Ventures Sooma Medical

2024

Growth Equity & Expansion Capital Alternative Medicine Facilities Finland
EW Healthcare Partners Grundium Oy

2023

Growth Equity & Expansion Capital Medical Diagnostic & Testing Equipment Finland
Verso Capital Vetrospace

2023

Growth Equity & Expansion Capital Healthcare Facilities & Services (NEC) Finland
Juuri Partners Mediconsult Oy

2023

Growth Equity & Expansion Capital Healthcare Facilities & Services (NEC) Finland
Nordic Secondary Fund II Pixieray Oy

2023

Growth Equity & Expansion Capital Glasses, Spectacles & Contact Lenses Finland

MB Rahastot

invested in

Spider Med Oy

in 2023

in a Growth Equity & Expansion Capital deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert